MariMed (OTCQX: MRMD, CSE: MRMD) Fundamental Stock Analysis | Small Cap Podcast

Описание: Welcome to this episode of the TDR Small Cap Podcast! Hosts Shadd Dales and William McNarland, CFA provide a comprehensive analysis of MariMed (OTC: MRMD, CSE: MRMD), A multi-state cannabis operator, MariMed specializes in cannabis cultivation and product development. We analyze their market presence, product lineup, and strategic initiatives.

In this video, we analyze MariMed compared to 13 other competitors:

• Company Overview
• Revenue Growth
• Gross Profit Margin
• Levered Free Cash Flow
• CAPEX

We analyze MariMed's market presence, product lineup, and strategic initiatives. Discover the growth catalysts, industry trends, and market dynamics in this expert analysis.

Like, Comment, Subscribe and Stay informed on the latest small-cap stocks and stock market trends by watching this valuable analysis. Share this video with fellow investors to spread the knowledge!
#smallcapstock #multibagger #pennystock #smallcapstockworthbuying #smallcapcompany #MariMedstock

Want to watch more videos about Small Cap Stocks?
   • Would We Buy These Five Small Cap Stocks? ...  
   • Trade to Black I Small Cap Sunday - Four S...  
   • Trade to Black Small Cap Sunday – Would We...  
   • Trade to Black Small Cap Sunday - Global O...  

Want to be updated on Cannabis, AI, Small Cap, and Crypto? Subscribe to our Daily Baked in Newsletter!
https://newsletter.thedalesreport.com...

Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:
Facebook:   / thedalesreport  
Twitter:   / thedalesreport  
Instagram:   / dalesreport  
Website: https://thedalesreport.com/

For copyright matters, please get in touch with us at:
[email protected]

Disclaimer:
All views on the TDR Small Cap Podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice.

https://thedalesreport.com/disclosure...